Eli Lilly is buying the psychedelics-focused biotech AtaiBeckley for $2.8 billion upfront, a move that will expand its ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — A Senate vote to halt ...

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health ...

Kalshi, one of the world’s largest prediction market exchanges, plans to take bets on clinical trials and regulatory ...

A brain-computer interface helped restore movement and sensation in a 48-year old man with quadriplegia, researchers say.

CMS wants to build a standardized payment structure for clinical software and AI that factors in their impact on patient ...

A trio of bipartisan lawmakers reintroduced a bill requiring the FTC and Treasury to investigate whether the U.S. relies too ...

Some of the most powerful medicines we will ever find are already here, carried in the fangs, stingers, and saliva of ...

Sean Kaufman, Trump's pick for a key pandemic preparedness role, has questioned vaccines and criticized the CDC.

Prediction markets have permeated the worlds of sports, politics, and reality television shows. Now, the biopharma industry ...

UnitedHealth Group smashed through investors’ earnings expectations in the second quarter, with executives confidently saying this new level of profit is durable for the foreseeable future. The ...

Mayo's AI whistleblower, Sutter Health's reply to lawsuit over Abridge scribe, and more.